GRAL

GRAIL
GRAL

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.49B
EV
$875.80M
Shares Outstanding
35.97M
Beta
-

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$31.50
P/E 2025E
-
P/Revenue 2025E
10.06x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About GRAIL, Inc.

gainify
GRAL

GRAIL, Inc.

GRAL

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic r...

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Ragusa, Robert

Employees

1,000

Website

grail.com

IPO Date

2024-06-12

Headquarters

1525 O’Brien Drive, Menlo Park, California, 94025, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.